Scabies clinical trials
The registry lists 51 studies for Scabies across more than 10 countries. 10 are recruiting or about to start. 38 of them are mainly about Scabies (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Scabies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
London School of Hygiene and Tropical Medicine (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Medicines Development for Global Health (3) · University of Oxford (2) · Murdoch Childrens Research Institute (2) · ParaPRO LLC (2) · Combined Military Hospital Abbottabad (2) · Infectopharm Arzneimittel GmbH (2)
What is being tested here
Drugs under test in Scabies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Permethrin | 1 | 7 | 13 |
| Ivermectin | 1 | 3 | 10 |
| Moxidectin | 1 | 0 | 3 |
| Sulfur | 0 | 1 | 2 |
| Azithromycin | 0 | 1 | 2 |
| Idarubicin | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4, phase 3 first
- Jun 2027Better Options for Lymphatic Filariasis Treatment · Phase 3 · Medicines Development for Global Health
- Jul 2027Therapy for Scabies With Two Differently Concentrated Permethrin Creams · Phase 3 · Infectopharm Arzneimittel GmbH
- Dec 2026Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) · Murdoch Childrens Research Institute
- Mar 2027Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis · Istanbul Medeniyet University
Who these studies take
Of the 4 Scabies studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 3 (75%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (75%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (50%) | 2 (50%) |
| 18 | 3 (75%) | 3 (75%) |
| 30 | 3 (75%) | 3 (75%) |
| 40 | 3 (75%) | 3 (75%) |
| 50 | 3 (75%) | 3 (75%) |
| 65 | 3 (75%) | 3 (75%) |
| 75 | 3 (75%) | 3 (75%) |
| 85 | 3 (75%) | 3 (75%) |
Across all 51 studies, recruiting or not: 27% stop at 75 or younger and 27% at 65; 84% take children; 0% are for women only and 0% for men only; 31% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 11, 2026.
Studies
Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.
- Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial IntelligenceNot yet recruitingNCT07904975Not applicable
- Better Options for Lymphatic Filariasis TreatmentRecruitingNCT07159373Phase 31 country
- Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic DermatitisNot yet recruitingNCT078136111 country
- Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health WorkersNot yet recruitingNCT07506967Not applicable5 countries
- Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young ChildrenNot yet recruitingNCT07247630Early Phase 11 country
- Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical DiseasesRecruitingNCT07145736Phase 41 country
- Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of ScabiesNot yet recruitingNCT06896929Phase 21 country
- PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age with ScabiesRecruitingNCT05310734Phase 41 country
- Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot StudyRecruitingNCT06546579Early Phase 11 country
- Therapy for Scabies With Two Differently Concentrated Permethrin CreamsNot yet recruitingNCT06380452Phase 3
- Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)Active, not recruitingNCT05500326Phase 21 country
- HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard FormulationSuspendedNCT06918665Phase 11 country
- Sulfur 7% Cream Compared With Permethrin 5% Cream for Treating Scabies in AdultsCompletedNCT07822672Phase 41 country
- Efficacy and Safety Study of Moxidectin in Adults With ScabiesCompletedNCT05875441Phase 24 countries
- National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of ScabiesCompletedNCT073059611 country
- Ivermectin Safety in Small ChildrenCompletedNCT04332068Phase 23 countries
- Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)CompletedNCT06404333Phase 21 country
- Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and AdultsCompletedNCT02407782Phase 32 countries
- Sulfur vs. Different Regimes of Permethrin for ScabiesCompletedNCT06396507Phase 31 country
- Dose-finding Study of Moxidectin for Treatment of ScabiesCompletedNCT03905265Phase 23 countries
- Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of ScabiesCompletedNCT05862701Phase 11 country
- A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of ScabiesCompletedNCT02094716Phase 24 countries
- Ivermectin/ Permethrin for ScabiesCompletedNCT05819983Phase 41 country
- Streptococcus Pyogenes Carriage Acquisition and Transmission StudyCompletedNCT051175281 country
- Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of ScabiesCompletedNCT05362513Phase 11 country
- Place of Hygiene in Scabies's Treatment in Populations in Precarious SituationsStatus unknownNCT05271968Not applicable1 country
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 31 country
- Better Disease Control by Multidrug Regimen in ScabiesCompletedNCT05198947Not applicable
- Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).CompletedNCT050946871 country
- Contagious Itch, Disgust and Empathy in Patients and Medical StaffCompletedNCT04557644Not applicable1 country
- Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of ScabiesCompletedNCT05025696Not applicable1 country
- Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)Status unknownNCT04814511Phase 31 country
- Risk Factors for Treatment Failure of Scabies in Autochthonous Populations of French Guiana (GUYAGALE)Status unknownNCT049316801 country
- Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of ScabiesCompletedNCT02485704Phase 31 country
- Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of ScabiesCompletedNCT02485717Phase 31 country
- Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in FijiCompletedNCT03177993Not applicable1 country
- Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, GabonCompletedNCT04205669Phase 41 country
- A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With ScabiesCompletedNCT03973775Phase 31 country
- Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.CompletedNCT02978508Phase 31 country
- Azithromycin - Ivermectin Mass Drug Administration for Skin DiseaseCompletedNCT02775617Phase 41 country
- Veron Scabies Education and Eradication ProgramCompletedNCT00604084Not applicable1 country
- Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon IslandsCompletedNCT03236168Phase 31 country
- Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of ScabiesCompletedNCT03178942Phase 33 countries
- Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03676140Phase 31 country
- PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes ScabieiCompletedNCT022545641 country
- A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of ScabiesCompletedNCT02572986Phase 33 countries
- Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern TerritoryCompletedNCT008847281 country
- Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in FijiCompletedNCT004368911 country
- Prevalence of RHD, Pyoderma and Scabies in Children in FijiCompletedNCT002848431 country
- Incidence of Group A Strep Pharyngitis in School Children in FijiCompletedNCT002848821 country